6-Chloro-N-(pyridin-2-yl)pyridine-3-sulfonamide

Catalog No. :
ACTZRX563
CAS No. :
622803-93-4
Molecular Formula :
C10H8ClN3O2S
Molecular Weight :
269.71

IUPAC Name:6-chloro-N-(pyridin-2-yl)pyridine-3-sulfonamide

6-Chloro-N-(pyridin-2-yl)pyridine-3-sulfonamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$142.00Login to see priceInquiryInquiry
100mg95%$207.00Login to see priceInquiryInquiry
250mg95%$286.00Login to see priceInquiryInquiry
1g95%$675.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name6-Chloro-N-(pyridin-2-yl)pyridine-3-sulfonamide
IUPAC Name6-chloro-N-(pyridin-2-yl)pyridine-3-sulfonamide
MDL No.MFCD06293053
Molecular FormulaC10H8ClN3O2S
Molecular Weight269.71
SMILESO=S(C1=CC=C(Cl)N=C1)(NC2=NC=CC=C2)=O
InChI KeyJKSGRKZYGYCNAW-UHFFFAOYSA-N
Synonym3-Pyridinesulfonamide, 6-chloro-N-2-pyridinyl-;6-chloro-pyridine-3-sulfonic acid-[2]pyridylamide
CAS No.622803-93-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACTZRX563 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACKWTD320 route compound structure diagram
    ACKWTD32032654-45-8 In Stock
  2. Plus
  3. ACJYCO531 route compound structure diagram
    ACJYCO5316684-39-5 In Stock
  4. Then
  5. ACTZRX563 route product structure diagram
    ACTZRX563622803-93-4
Inquiry

2. ACTZRX563 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACKWTD320 route compound structure diagram
    ACKWTD32032654-45-8 In Stock
  2. Plus
  3. ACXCYA693 route compound structure diagram
    ACXCYA69317624-08-7
  4. Then
  5. ACTZRX563 route product structure diagram
    ACTZRX563622803-93-4
Inquiry

Comments (0)